Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.
<h4>Aim</h4>To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy.<h4>Methodology</h4>This is a cross-sectional, prospective and observational study involving interviews with 410 patients who...
Guardado en:
Autores principales: | Lorena Maria Lima de Araújo, Maria Vivyanne de Moura Lopes, Rafael Silva de Arruda, Rand Randall Martins, Antonio Gouveia Oliveira |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d158349e62ad49f897372c89e2b8b239 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
por: Angela Horvath, et al.
Publicado: (2019) -
The proton-pump inhibitor lansoprazole enhances amyloid beta production.
por: Nahuai Badiola, et al.
Publicado: (2013) -
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang XY, et al.
Publicado: (2021) -
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
por: Anne T Nies, et al.
Publicado: (2011) -
Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba I, et al.
Publicado: (2016)